Stock JAZZ JAZZ PHARMACEUTICALS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Company Jazz Pharmaceuticals plc

Equities

JAZZ

IE00B4Q5ZN47

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
106.3 USD -0.24% Intraday chart for Jazz Pharmaceuticals plc +0.82% -13.56%
Jun. 06 Transcript : Jazz Pharmaceuticals plc Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 02:00 PM
Jun. 01 Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 CI

Business Summary

Jazz Pharmaceuticals PLC is a biotechnology company. The Company is engaged in developing medicines for people with serious diseases. The Company’s lead marketed products include Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution, Xyrem (sodium oxybate) oral solution, Epidiolex (cannabidiol) oral solution, Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn), Zepzelca (lurbinectedin), Defitelio (defibrotide sodium) AND Vyxeos (daunorubicin and cytarabine) liposome for injection. The Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution product is for the treatment of cataplexy or excessive daytime sleepiness (EDS), in patients with narcolepsy seven years of age and older. The Xyrem (sodium oxybate) oral solution product is for the treatment of cataplexy or EDS in patients with narcolepsy seven years of age and older. The Defitelio (defibrotide sodium) product is for the treatment of hepatic veno-occlusive disease (VOD).

Number of employees: 2,800

Sales per Business

USD in Million2022Weight2023Weight Delta
Pharmaceutical Products
100.0 %
3,659 100.0 % 3,834 100.0 % +4.78%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
91.0 %
3,370 92.1 % 3,490 91.0 % +3.55%
Europe
7.0 %
240 6.5 % 269 7.0 % +12.35%
All Other
2.0 %
49 1.3 % 75 2.0 % +51.92%

Managers

Managers TitleAgeSince
Bruce Cozadd CEO
 Chief Executive Officer 60 03-02-28
Renée Galá PSD
 President 52 20-03-15
Robert Iannone CTO
 Chief Tech/Sci/R&D Officer 57 19-05-28
Seamus Mulligan BRD
 Director/Board Member 63 12-01-17
Andrea N. Flynn IRC
 Investor Relations Contact - -
Shawn Mindus PRN
 Corporate Officer/Principal - -
John Miller PRN
 Corporate Officer/Principal - -
Heidi Manna HRO
 Human Resources Officer 53 18-10-31
Neena Patil LAW
 General Counsel 49 19-06-30
Aislinn Doody SEC
 Corporate Secretary - -

Members of the board

Members of the board TitleAgeSince
Bruce Cozadd CEO
 Chief Executive Officer 60 03-02-28
Norbert Riedel BRD
 Director/Board Member 66 13-05-12
Patrick Enright BRD
 Director/Board Member 62 08-12-31
Peter Gray BRD
 Director/Board Member 69 13-05-07
Ken O'Keefe BRD
 Director/Board Member 57 03-12-31
Rick Winningham BRD
 Director/Board Member 64 09-12-31
Seamus Mulligan BRD
 Director/Board Member 63 12-01-17
Heather McSharry BRD
 Director/Board Member 62 13-05-01
Catherine Sohn BRD
 Director/Board Member 71 12-07-26
Anne O’Riordan BRD
 Director/Board Member 56 19-02-13

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 63,039,618 61,286,901 ( 97.22 %) 0 97.22 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
10.23 %
6,448,689 10.23 % 693 M $
BlackRock Advisors LLC
9.548 %
6,018,908 9.548 % 647 M $
STATE STREET CORPORATION
3.906 %
2,462,135 3.906 % 265 M $
LSV Asset Management
3.777 %
2,380,858 3.777 % 256 M $
JPMorgan Investment Management, Inc.
2.363 %
1,489,636 2.363 % 160 M $
Polaris Capital Management LLC
2.273 %
1,432,660 2.273 % 154 M $
Capital Research & Management Co. (World Investors)
2.265 %
1,427,860 2.265 % 153 M $
Ameriprise Financial Services LLC
2.172 %
1,368,949 2.172 % 147 M $
Pacer Advisors, Inc.
2.052 %
1,293,726 2.052 % 139 M $
Seamus Mulligan
1.855 %
1,169,300 1.855 % 126 M $

Company contact information

Jazz Pharmaceuticals Plc

Waterloo Exchange Waterloo Road

4, Dublin

+353 1 634 7800

http://www.jazzpharmaceuticals.com
address Jazz Pharmaceuticals plc(JAZZ)

Group companies

NameCategory and Sector
Jazz Securities DAC
Finance/Rental/Leasing
Jazz Investments II Ltd.
Finance/Rental/Leasing
Jazz Financing Holdings Ltd.
Logo Jazz Financing Holdings Ltd.

Jazz Financing Holdings Ltd.

MiscellaneousMiscellaneous

Part of Jazz Pharmaceuticals Plc, Jazz Financing Holdings Ltd. is an investment holding Irish company. The company is located in Ireland.

Miscellaneous
Jazz Investments Europe Ltd.
Jazz Pharmaceuticals Ireland Ltd.
Logo Jazz Pharmaceuticals Ireland Ltd.

Jazz Pharmaceuticals Ireland Ltd.

Pharmaceuticals: MajorHealth Technology

Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Ireland Ltd. is an Irish biopharmaceutical company that focuses on the identification, development, and commercialization of pharmaceutical products. The company is based in Dublin, Ireland. The company was founded by Bruce C. Cozadd, who has been the CEO since incorporation.

Pharmaceuticals: Major
Jazz Financing I DAC
Finance/Rental/Leasing
Jazz Pharmaceuticals Ireland Holdings Ltd.
Jazz Financing Lux SARL
Logo Jazz Financing Lux SARL

Jazz Financing Lux SARL

Finance/Rental/LeasingFinance

Part of Jazz Pharmaceuticals Plc, Jazz Financing Lux SARL provides financing services. The company is based in Luxembourg, Luxembourg. Founded in 2013.

Finance/Rental/Leasing

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Ratings for Jazz Pharmaceuticals plc

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
106.3 USD
Average target price
180.3 USD
Spread / Average Target
+69.55%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
JAZZ PHARMACEUTICALS PLC Stock Jazz Pharmaceuticals plc
-13.56% 6.7B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+43.64% 754B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+39.42% 630B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.58% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.72% 331B
ABBVIE INC. Stock AbbVie Inc.
+8.78% 298B
NOVARTIS AG Stock Novartis AG
+11.92% 217B
ROCHE HOLDING AG Stock Roche Holding AG
-2.62% 216B
PFIZER, INC. Stock Pfizer, Inc.
+0.03% 163B
AMGEN INC. Stock Amgen Inc.
+6.13% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. JAZZ Stock
  4. Company Jazz Pharmaceuticals plc